Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in breast and colorectal cancer
2007-004853-27Phase 4Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Complete response rate. Started Sep 2007; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2007-004853-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004853-27.